RIG-I ligand enhances the immunogenicity of recombinant H7HA protein.
Cell Immunol
; 304-305: 55-8, 2016.
Article
em En
| MEDLINE
| ID: mdl-27106062
ABSTRACT
Avian H7N9 influenza virus infection with fatal outcomes continues to pose a pandemic threat and highly immunogenic vaccines are urgently needed. In this report we show that baculovirus-derived recombinant H7 hemagglutinin protein, when delivered with RIG-I ligand, induced enhanced antibody and T cell responses and conferred protection against lethal challenge with a homologous H7N9 virus. These findings indicate the potential utility of RIG-I ligands as vaccine adjuvants to increase the immunogenicity of recombinant H7 hemagglutinin.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Vacinas contra Influenza
/
Linfócitos T
/
Infecções por Orthomyxoviridae
/
Glicoproteínas de Hemaglutininação de Vírus da Influenza
/
Influenza Humana
/
Subtipo H7N9 do Vírus da Influenza A
/
Proteína DEAD-box 58
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article